Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Soleno Therapeutics (SLNO) Preferred Shares Issued (2016)

Soleno Therapeutics (SLNO) has disclosed Preferred Shares Issued for 2 consecutive years, with $185.0 as the latest value for Q4 2016.

  • Quarterly Preferred Shares Issued fell 100.0% to $185.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $185.0 through Sep 2017, down 100.0% year-over-year, with the annual reading at $13.5 million for FY2016, 218.65% up from the prior year.
  • Preferred Shares Issued for Q4 2016 was $185.0 at Soleno Therapeutics, down from $8.4 million in the prior quarter.
  • The five-year high for Preferred Shares Issued was $8.4 million in Q3 2016, with the low at $185.0 in Q4 2016.